MÓNICA DEL
REY GONZÁLEZ
Investigadora en el periodo 2019-2021
Jesús María
Hernández Rivas
Catedrático de Universidad
Publicaciones en las que colabora con Jesús María Hernández Rivas (13)
2024
-
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromes
Nature Communications, Vol. 15, Núm. 1
-
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial
The Lancet Haematology
2023
2022
-
MDS-454 SF3B1 and DNMT3A Mutations Might Play a Role in Poor Prognosis and AML Progression in Patients With Isolated del(5q) MDS
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316
-
MDS-472 STAG2 and SRSF2 Mutations Might Define Prognosis of MDS Patients With Isolated Trisomy 8
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S316-S317
2020
-
Genome-wide transcriptomics leads to the identification of deregulated genes after deferasirox therapy in low-risk MDS patients
Pharmacogenomics Journal, Vol. 20, Núm. 5, pp. 664-671
2018
-
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders
Haematologica, Vol. 103, Núm. 1, pp. 148-162
2017
-
A two-step approach for sequencing spliceosome-related genes as a complementary diagnostic assay in MDS patients with ringed sideroblasts
Leukemia Research, Vol. 56, pp. 82-87
2016
-
Bone marrow fibrosis in myelodysplastic syndromes: A prospective evaluation including mutational analysis
Oncotarget, Vol. 7, Núm. 21, pp. 30492-30503
-
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
Haemophilia, Vol. 22, Núm. 4, pp. 590-597
2015
2013
-
Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia
PLoS ONE, Vol. 8, Núm. 1
-
Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes
Leukemia, Vol. 27, Núm. 3, pp. 610-618